Fundraising Fox
/Companies
Sign in

Omnix Medical

11 known investors

Find your way into Omnix Medical

169 people in our graph share verified history with the Omnix Medical team — schools, employers, funds. One of them is your warm intro.

Ran Achituvunlockedknows Moshik Cohen-Kutner · together at Omnix Medical (overlapped)
×2knows the team · via Omnix Medical
×9knows the team · via The Hebrew University of Jerusalem

Omnix Medical is a biopharmaceutical company founded in 2015 that develops novel antibiotic agents to treat infections caused by drug-resistant bacteria. Its lead compound, OMN6, is a first-in-class antimicrobial in Phase II clinical trials targeting drug-resistant Acinetobacter baumannii infections.

BiotechHealthtechMedical Devices

Founders & leadership

MCMoshik Cohen-Kutner
Moshik Cohen-KutnerCo Founder & CEOMoshik Cohen-Kutner holds a Ph.D. in Biochemistry and Molecular Biology from The Hebrew University and brings experience in pharmaceutical development and cancer research. He is Chief Executive Officer of Omnix Medical, a biopharmaceutical company developing novel antibiotics for drug-resistant bacterial infections.

Investors · 11

Xenia Venture Capital✓ confirmed by Omnix MedicalTel Aviv

How we know: the company's own site · Not right? Tell us

Entrée Capitallisted by Entrée CapitalTel Aviv · $150K – $15M

How we know: Entrée Capital's portfolio page · calcalistech.com · the VCSheet dataset · Not right? Tell us

OurCrowdreportedJerusalem · $604K – $65M

How we know: calcalistech.com · Not right? Tell us

VLX VenturesreportedJerusalem · $700K – $1M

How we know: funding news · Not right? Tell us

Also in the syndicate · 6

EIC FundleadEuropean Innovation Council (EIC) FundleadHarel Insurance & FinanceleadOriella LimitedPrevail PartnersXenia Ventures

Funding

SEC filings, press & company announcements

$25M disclosed across 1 round · 2025

  • $25MSeries COct 2025 · 3 sources

    EIC Fund (lead), European Innovation Council (EIC) Fund (lead), Harel Insurance & Finance (lead), Entrée Capital, Oriella Limited, OurCrowd, Prevail Partners, Tal Ventures, Xenia Ventures

    Source ↗

Source: company announcements and press reports — follow each round's link for the claim.

In the news

Omnix Medical Secures $25 Million in Series C Funding Co-Led by Harel Insurance & Finance and the EIC Fund - BioSpacebiospace.com · Oct 2025Omnix Medical Secures $25 Million in Series C Funding Co-Led by Harel Insurance & Finance and the EIC Fundglobenewswire.com · Oct 2025News & Publications - Omnix Medicalomnixmedical.com · Apr 2021

Frequently asked questions

What does Omnix Medical do?
Omnix Medical is a biopharmaceutical company founded in 2015 that develops novel antibiotic agents to treat infections caused by drug-resistant bacteria. Its lead compound, OMN6, is a first-in-class antimicrobial in Phase II clinical trials targeting drug-resistant Acinetobacter baumannii infections.
Who are Omnix Medical's investors?
Omnix Medical's investors include Tal Ventures, Xenia Venture Capital, Entrée Capital, OurCrowd, VLX Ventures.
How much funding has Omnix Medical raised?
Omnix Medical has disclosed $25M raised across 1 round.